Explore All Access
Check if your research matches the topics covered in Translational Cancer Research?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Translational Cancer Research : Impact Factor & More
eISSN: 2219-6803pISSN: 2218-676X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Translational Cancer Research Key Metrics
CiteScore 
0.8
Impact Factor
< 5
SJR
Q4Oncology
SNIP
0.16
Topics Covered on Translational Cancer Research
Cancer
Cell growth
Overall survival
Lung cancer
Lymph node
Bioinformatics analysis
Portal vein
Chemoradiotherapy
Small intestine
Immunotherapy
Breast cancer
Hepatocellular carcinoma
Crizotinib
Epidermal growth factor receptor
Key genes
Extracellular vesicles
Nasopharyngeal carcinoma
Head and neck
Hepatitis B
Carcinogenesis
Translational Cancer Research Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Translational Cancer Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Translational Cancer Research
Identification and validation of a novel innate lymphoid cell-based signature to predict prognosis and immune response in liver cancer by integrated single-cell RNA analysis and bulk RNA sequencing.
- 1 Oct 2024
- Translational cancer research
The pan-cancer landscape of crosstalk between leukocyte transendothelial migration-related genes and tumor microenvironment relevant to prognosis and immunotherapy response.
- 1 Oct 2024
- Translational cancer research
Integrated analysis reveals prognostic correlation and immune characteristics of a tumor-associated macrophage-based risk signature in triple-negative breast cancer.
- 1 Oct 2024
- Translational cancer research
The potential role of Ral-interacting protein 76 and vascular endothelial growth factor on angiogenesis in the tumor and ovarian corpus luteum microenvironment.
- 1 Oct 2024
- Translational cancer research
ISL1 and AQP5 complement each other to enhance gastric cancer cell stemness by regulating CD44 expression.
- 1 Oct 2024
- Translational cancer research
Sini decoction-polysaccharide compound regulates proliferation, apoptosis, and glycolysis of liver cancer cells through PHLDA2/ANXA2.
- 1 Oct 2024
- Translational cancer research
Identification and validation of a novel innate lymphoid cell-based signature to predict prognosis and immune response in liver cancer by integrated single-cell RNA analysis and bulk RNA sequencing.
- 1 Oct 2024
- Translational cancer research
The pan-cancer landscape of crosstalk between leukocyte transendothelial migration-related genes and tumor microenvironment relevant to prognosis and immunotherapy response.
- 1 Oct 2024
- Translational cancer research
Integrated analysis reveals prognostic correlation and immune characteristics of a tumor-associated macrophage-based risk signature in triple-negative breast cancer.
- 1 Oct 2024
- Translational cancer research
The potential role of Ral-interacting protein 76 and vascular endothelial growth factor on angiogenesis in the tumor and ovarian corpus luteum microenvironment.
- 1 Oct 2024
- Translational cancer research
ISL1 and AQP5 complement each other to enhance gastric cancer cell stemness by regulating CD44 expression.
- 1 Oct 2024
- Translational cancer research
Sini decoction-polysaccharide compound regulates proliferation, apoptosis, and glycolysis of liver cancer cells through PHLDA2/ANXA2.
- 1 Oct 2024
- Translational cancer research
Compare Similar Journals with Translational Cancer Research
Select Journals to Compare with Translational Cancer Research
Total journals - 10
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
OncoTargets and Therapy
Publisher: DOVE MEDICAL PRESS LTD
Annals of Oncology
Publisher: ELSEVIER
Cancers
Publisher: MDPI
BMC Cancer
Publisher: BMC
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Oncotarget
Publisher: Impact Journals
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
Translational Cancer Research
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Translational Cancer Research
How long has Translational Cancer Research been actively publishing? 
Translational Cancer Research has been in operation since 2012 till date.
What is the publishing frequency of Translational Cancer Research?
Translational Cancer Research published with a Monthly frequency.
How many articles did Translational Cancer Research publish last year?
In 2023, Translational Cancer Research publsihed 376 articles.
What is the eISSN & pISSN for Translational Cancer Research?
For Translational Cancer Research, eISSN is 2219-6803 and pISSN is 2218-676X.
What is Citescore for Translational Cancer Research?
Citescore for Translational Cancer Research is 0.8.
What is SNIP score for Translational Cancer Research?
SNIP score for Translational Cancer Research is 0.16.
What is the SJR for Translational Cancer Research?
SJR for Translational Cancer Research is Q4.
Who is the publisher of Translational Cancer Research?
AME PUBLISHING COMPANY is the publisher of Translational Cancer Research.
